Copenhagen Conference: Legal Perspectives on Synthetic Biology and Gene Editing

Join us at the Centre for Information and Innovation Law (CIIR) Faculty of Law, University of Copenhagen on 20 November, 2017 to discuss Legal Perspectives on Synthetic Biology and Gene Editing.

CALL FOR PAPERS

Emerging technologies in Synthetic Biology and Gene Editing offer incredible opportunities and promising solutions to some of the most urgent challenges faced by humanity, such as climate change, environmental protection, growing population, renewable energy and improved health care. But the emerging applications also raise exceptional ethical, legal and social questions.

This conference marks the final phase of the participation of the Copenhagen Biotech and Pharma Forum (CBPF) Research Group at the Centre for Information and Innovation Law (CIIR) in the cross-faculty research project BioSYNergy. In accordance with the goals of this large cross-faculty project on Synthetic Biology, the event explores legal perspectives on synthetic biology, systems biology and gene editing. Dealing with the legal responses to ethical and scientific challenges raised by emerging life science technology.

Taking into account the newest scientific developments and challenges, invited speakers will debate the legal implications of bio-pharma innovation in synthetic biology and gene editing. The conference will explore interfaces between Law, Science, Ethics and Commercialization of Bio-pharma innovation, with a focus on:

  • Gene editing regulation and applications
  • IP and Innovation
  • Licensing and Collaboration
  • Ethics and Human Enhancement

Abstracts (max 500 words) to be submitted until 13 September 2017 to: ana.nordberg@jur.ku.dk.

An edited volume based on the conference proceedings is being projected, selected speakers will be invited to contribute with a chapter (8,000-10,000 words incl. footnotes and bibliography).

Early expressions of interest or full paper submissions are most welcome.

Organizers: Postdoctoral Fellow Ana Nordberg; Prof. Timo Minssen; Research Fellow Jakob Wested

Contact: Ana.nordberg@jur.ku.dk

*Final date to be announced.

Registration:
The event is free to attend. Registration is mandatory. Please use this registration form no later than Thursday, 16 November 2017 at the latest.

Timo Minssen

Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research concentrates on Intellectual Property-, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors including biologics and biosimilars. His studies comprise a plethora of legal issues emerging in the lifecycle of biotechnological and medical products and processes - from the regulation of research and incentives for innovation to technology transfer and commercialization.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.